The most common form of unpreventable blindness, dry-AMD affects the vision of millions of Americans. Click here to learn more about dry-AMD and Alkeus Pharma future trials.
A rare genetic disease, Stargardt disease is a major cause of blindness in children and is currently untreatable and irreversible. Click this box to stay informed of Alkeus Pharma upcoming clinical trials.
Alkeus Pharma drug candidates result from years of research by leading ophthalmic scientists. Click here to learn more about vision, our scientific approach and our preclinical animal data.
Our team is experienced and dedicated to developing treatments for blindness. We
collaborate heavily with leading physicians worldwide. Click here to learn more about Alkeus Pharma.